Regulatory Affairs

Is Your Trial Data Audit-Ready? GCP Regulatory Requirements Sponsors Often Miss

By |2026-10-13T09:59:49+00:00October 12, 2026|GCP Audit, Regulatory Affairs|

Most clinical data integrity findings don't start with fraud. They start with unreviewed audit trails, late source entries, and records that don't match the EDC. For sponsors and CROs ...

Why GMP Audits Reveal Compliance Risks in Your Operation More Efficiently

By |2026-09-03T10:00:40+00:00August 5, 2026|GMP Audit, GMP Compliance, Regulatory Affairs|

Everything is going smoothly in your organization: SOPs are up-to-date, batches are well-documented, and all the activities within the QM system seem to be running in the proper way. ...

The Mistake Almost Every Pharmaceutical Facility Makes When Preparing for Inspection

By |2026-09-19T09:27:48+00:00August 3, 2026|GMP Compliance, Regulatory Affairs|

Preparation for regulatory inspections involves a lot of work. Documents are organized in the final weeks. Standard Operating Procedures (SOP) undergo a quick review. Training is performed again. The ...

GMP Audit Services: What Pharma Companies Risk Every Day They Delay

By |2026-09-19T09:26:22+00:00July 4, 2026|GMP Audit, GMP Compliance, Regulatory Affairs|

FDA issued over 50 warning letters in 2023 due to GMP violations which could easily be discovered with a reliable gmp audit service provider. A generic drugs maker in ...

Choosing the Right GMP Compliance Company in India for Sustainable Regulatory Success

By |2026-09-19T08:46:15+00:00July 1, 2026|GMP Audit, GMP Compliance, Pharma Industry India, Quality Assurance & Compliance, Regulatory Affairs|

Every manufacturer knows how the atmosphere is in the plant prior to a regulatory inspection. Floors are clean; logbooks are in order; and somebody in QA hopes the inspector ...

Go to Top